Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
OBJECTIVES: Observational and genetic studies have shown that lipoprotein(a) [Lp(a)] levels and apolipoprotein(a) [apo(a)] isoform size are both associated with coronary heart disease (CHD) risk, but the relative independence of these risk factors remains unclear. Clarification of this uncertainty i...
主要な著者: | Hopewell, J, Seedorf, U, Farrall, M, Parish, S, Kyriakou, T, Goel, A, Hamsten, A, Collins, R, Watkins, H, Clarke, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2014
|
類似資料
-
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
著者:: Hopewell, J, 等
出版事項: (2014) -
Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
著者:: Hopewell, J, 等
出版事項: (2010) -
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
著者:: Kyriakou, T, 等
出版事項: (2014) -
A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
著者:: Kyriakou, T, 等
出版事項: (2014) -
LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
著者:: Kyriakou, T, 等
出版事項: (2014)